6 Einträge gefunden

1. Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer:AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial

   1. Pfisterer, Jacobus
   2. Joly, Florence
   3. Kristensen, Gunnar
   4. Rau, Joern
   5. Mahner, Sven
   6. Pautier, Patricia
   7. El-Balat, Ahmed

   2023 - Forschungsinformationssystem des UKE
2. Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study

   1. Woelber, Linn
   2. Hampl, Monika
   3. Eulenburg, Christine Zu
   4. Prieske, Katharina
   5. Hambrecht, Johanna
   6. Fuerst, Sophie
   7. Klapdor, Ruediger

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

   1. Pfisterer, Jacobus
   2. Shannon, Catherine M
   3. Baumann, Klaus
   4. Rau, Joern
   5. Harter, Philipp
   6. Joly, Florence
   7. Sehouli, Jalid

   2020 - Forschungsinformationssystem des UKE
4. Prognostic role of thrombocytosis in recurrent ovarian cancer:a pooled analysis of the AGO Study Group

   1. Canzler, Ulrich
   2. Lück, Hans-Joachim
   3. Neuser, Petra
   4. Sehouli, Jalid
   5. Burges, Alexander
   6. Harter, Philipp
   7. Schmalfeldt, Barbara

   2020 - Forschungsinformationssystem des UKE
5. Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study

   1. Klapdor, Rüdiger
   2. Wölber, Linn
   3. Hanker, Lars
   4. Schmalfeldt, Barbara
   5. Canzler, Ulrich
   6. Fehm, Tanja
   7. Luyten, Alexander

   2019 - Forschungsinformationssystem des UKE
6. Propensity Scoring after Multiple Imputation in a Retrospective Study on Adjuvant Radiation Therapy in Lymph-Node Positive Vulvar Cancer

   1. zu Eulenburg, Christine
   2. Suling, Anna
   3. Neuser, Petra
   4. Reuss, Alexander
   5. Canzler, Ulrich
   6. Fehm, Tanja
   7. Luyten, Alexander

   2016 - Forschungsinformationssystem des UKE - frei zugänglich